About AD ASTRA DIAGNOSTICS, INC.
Ad Astra Diagnostics develops point-of-care diagnostic solutions, including the QScout CBC and QScout RLD, which provide rapid blood analysis without the need for wet reagents or liquid handling. The company focuses on delivering lab-quality results at a lower cost for use in clinical settings.
Point-of-care blood analysisRapid CBC testing from fingerstick or venous bloodMeasurement of immature granulocytes for early sepsis detection
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| AD ASTRA DIAGNOSTICS, INC. (PLUS) &D FOR CLIA-WAIVED UBIQUITOUS EARLY SEPSIS DETECTION, SEVERITY IN AMBULANCE, | Department of Health and Human Services | $6.7M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AD ASTRA DIAGNOSTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.